BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31801358)

  • 1. Chinese Herbal Medicine-Based Cancer Therapy: Novel Anticancer Agents Targeting MicroRNAs to Regulate Tumor Growth and Metastasis.
    Peng F; Xie X; Peng C
    Am J Chin Med; 2019; 47(8):1711-1735. PubMed ID: 31801358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer activities of TCM and their active components against tumor metastasis.
    Wang K; Chen Q; Shao Y; Yin S; Liu C; Liu Y; Wang R; Wang T; Qiu Y; Yu H
    Biomed Pharmacother; 2021 Jan; 133():111044. PubMed ID: 33378952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Properties of Traditional Chinese Medicine.
    Yan Z; Lai Z; Lin J
    Comb Chem High Throughput Screen; 2017; 20(5):423-429. PubMed ID: 28093974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Traditional Chinese Medicines as Personalized Therapy in Human Cancers.
    Wang S; Long S; Wu W
    Am J Chin Med; 2018; 46(5):953-970. PubMed ID: 29986595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds.
    Hong M; Tan HY; Li S; Cheung F; Wang N; Nagamatsu T; Feng Y
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of immunity-enhancing traditional Chinese medicine.
    Wang Y; Zhang Q; Chen Y; Liang CL; Liu H; Qiu F; Dai Z
    Biomed Pharmacother; 2020 Jan; 121():109570. PubMed ID: 31710893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Advances in the Intervention of Inflammation and Cancer by Active Ingredients of Traditional Chinese Medicine.
    Huang Y; Cai T; Xia X; Cai Y; Wu XY
    J Pharm Pharm Sci; 2016; 19(1):114-26. PubMed ID: 27096696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review.
    Zhai B; Zhang N; Han X; Li Q; Zhang M; Chen X; Li G; Zhang R; Chen P; Wang W; Li C; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
    Biomed Pharmacother; 2019 Jun; 114():108812. PubMed ID: 30965237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress on synergistic anti-tumor mechanisms of compounds in traditional Chinese medicine.
    Zhou J; Zhou T; Jiang M; Wang X; Liu Q; Zhan Z; Zhang X
    J Tradit Chin Med; 2014 Feb; 34(1):100-5. PubMed ID: 25102699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of miRNAs by herbal medicine: An emerging field in cancer therapies.
    Mohammadi A; Mansoori B; Baradaran B
    Biomed Pharmacother; 2017 Feb; 86():262-270. PubMed ID: 28006752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network.
    Shen A; Lin W; Chen Y; Liu L; Chen H; Zhuang Q; Lin J; Sferra TJ; Peng J
    Int J Oncol; 2015 Feb; 46(2):685-90. PubMed ID: 25422078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM).
    Liu Y; Feng N
    Adv Colloid Interface Sci; 2015 Jul; 221():60-76. PubMed ID: 25999266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Use of Traditional Chinese Medicine Herbal Therapy and Survival Outcomes in Patients With Stage II and III Colorectal Cancer: A Multicenter Prospective Cohort Study.
    Xu Y; Mao JJ; Sun L; Yang L; Li J; Hao Y; Li H; Hou W; Chu Y; Bai Y; Jia X; Wang J; Shen L; Zhang Y; Wang J; Liu J; Yang Y
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review.
    Huang Z; Huang Q; Ji L; Wang Y; Qi X; Liu L; Liu Z; Lu L
    Pharmacol Res; 2016 Dec; 114():1-12. PubMed ID: 27697644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates.
    Xiao XH; Lv LC; Duan J; Wu YM; He SJ; Hu ZZ; Xiong LX
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29596304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Chinese medicine in the treatment of breast cancer.
    Cohen I; Tagliaferri M; Tripathy D
    Semin Oncol; 2002 Dec; 29(6):563-74. PubMed ID: 12516039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs.
    Meng QX; Roubin RH; Hanrahan JR
    J Ethnopharmacol; 2013 Jun; 148(1):229-38. PubMed ID: 23623820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Fatty Oils from Traditional Chinese Medicine in Cancer Therapy: A Review for Phytochemical, Pharmacological and Clinical Studies.
    Huang Y; Zhu J; Lin X; Hong Y; Feng Y; Shen L
    Am J Chin Med; 2019; 47(4):727-750. PubMed ID: 31094213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray-based expression of DNA repair genes does not correlate with growth inhibition of cancer cells by natural products derived from traditional Chinese medicine.
    Konkimalla VS; Wang G; Kaina B; Efferth T
    Cancer Genomics Proteomics; 2008; 5(2):79-84. PubMed ID: 18460736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.